Literature DB >> 25781574

Lung cancer: Driver-mutation-dependent stratification: learning from STAT3.

Alessia Errico.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25781574     DOI： 10.1038/nrclinonc.2015.52

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.

Authors:  Beatrice Grabner; Daniel Schramek; Kristina M Mueller; Herwig P Moll; Jasmin Svinka; Thomas Hoffmann; Eva Bauer; Leander Blaas; Natascha Hruschka; Katalin Zboray; Patricia Stiedl; Harini Nivarthi; Edith Bogner; Wolfgang Gruber; Thomas Mohr; Ralf Harun Zwick; Lukas Kenner; Valeria Poli; Fritz Aberger; Dagmar Stoiber; Gerda Egger; Harald Esterbauer; Johannes Zuber; Richard Moriggl; Robert Eferl; Balázs Győrffy; Josef M Penninger; Helmut Popper; Emilio Casanova
Journal:  Nat Commun       Date:  2015-03-03       Impact factor: 14.919
  1 in total
  2 in total

1.  Rig-G is a growth inhibitory factor of lung cancer cells that suppresses STAT3 and NF-κB.

Authors:  Dong Li; Junjun Sun; Wenfang Liu; Xuan Wang; Robert Bals; Junlu Wu; Wenqiang Quan; Yiwen Yao; Yu Zhang; Hong Zhou; Kaiyin Wu
Journal:  Oncotarget       Date:  2016-10-04

2.  The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression.

Authors:  Cheng-Cao Sun; Shu-Jun Li; Feng Zhang; Ya-Dong Zhang; Zhen-Yu Zuo; Yong-Yong Xi; Liang Wang; De-Jia Li
Journal:  Mol Ther Nucleic Acids       Date:  2016-11-15       Impact factor: 10.183
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.